IR: The Root Cause
Evidence & Methodology
The correlation data explained — how the r values were calculated, what they measure, and why they are scientifically valid
1The Central Question
Why do nine conditions as apparently different as ADHD, multiple sclerosis, IBS, hypertension, stroke, asthma, arthritis, OCD, and Type 2 diabetes all show a strikingly parallel rise in both the USA and UK over the same 50-year period — a period during which insulin resistance has also risen dramatically in both countries?
The answer proposed here is not that insulin resistance causes each of these conditions in the same way. The answer is more precise and more useful than that: insulin resistance creates the upstream biological conditions — chronic systemic inflammation, hyperinsulinaemia, oxidative stress, gut barrier dysfunction, and neuroinflammation — that allow each of these conditions to emerge or accelerate, in the specific organ or system where an individual is most vulnerable.
Insulin resistance does not cause “a disease.” It creates a state of chronic low-grade inflammation, impaired cellular energy metabolism, gut dysbiosis, and hormonal dysregulation that the body expresses through whichever pathway is most vulnerable in that individual person — determined by their genetics, constitutional type, gut microbiome, early-life exposures, stress history, and nutritional status.
The same fire. Different rooms. Determined by individual physiology.
2What the Correlation Data Shows — and What It Does Not
2.1 What the r values on the website measure
The Pearson correlation coefficients (r values) displayed on forradianthealth.com/insulin-resistance-the-root-cause are 50-year population-level ecological time-series correlations. They measure the degree to which two indexed prevalence trends — rising insulin resistance/metabolic syndrome in the population, and rising prevalence of each condition — have moved in parallel over 1975–2025, in both the USA and UK, with all series normalised to 1975 = 1.0.
This is a recognised and well-established epidemiological method. It is the same method that first identified the correlation between rising cigarette consumption and lung cancer mortality, and between rising obesity rates and Type 2 diabetes — in each case decades before the molecular mechanisms were fully characterised.
2.2 Why these r values are higher than clinical cross-sectional correlations
A separate and entirely valid set of r values exists in the clinical literature. These are cross-sectional correlations — measured within a group of individuals at a single point in time — between an individual’s IR marker (e.g. HOMA-IR) and their level of disease severity. These typically range from r=0.27 to r=0.82 depending on the condition. They are lower for a straightforward statistical reason: cross-sectional studies include enormous individual variation (age, sex, genetics, medication, comorbidities) that adds noise and reduces the r value.
The two types of r value are measuring different things and should not be confused or compared as if one is “correct” and the other is not.
| Type of correlation | What it measures | Typical range |
|---|---|---|
| Ecological time-series (50-year population trend) |
The parallel rise of IR and each condition across entire populations over decades. Both variables rise continuously, producing high r values. | 0.83–0.98 This website |
| Cross-sectional clinical (single study, individuals) |
Within a patient group at one point in time: does higher HOMA-IR correlate with worse disease outcomes? Individual variation reduces r. | 0.27–0.82 Published literature |
Neither set of r values proves causation. Both support the hypothesis. The ecological correlations establish that something linking the rise of IR and the rise of these conditions is operating at a population level across two countries over 50 years. The clinical correlations show that within individuals, higher IR is consistently associated with worse outcomes across all nine conditions. Together they make a coherent and evidence-based case.
3The Unifying Mechanism — Why One Root Can Have Nine Branches
The question people rightly ask is: how can the same underlying condition produce such apparently different diseases? The answer lies in understanding what insulin resistance actually does to the body at the cellular and systemic level — and recognising that most of these effects are non-specific. They create a biological environment in which multiple disease pathways become more likely to activate.
3.1 The five downstream effects of chronic insulin resistance
When insulin resistance becomes chronic, it produces five cascading biological consequences that operate simultaneously throughout the body:
| Downstream effect | What this means for the body |
|---|---|
| 1. Hyperinsulinaemia | Compensatory overproduction of insulin by the pancreas. High circulating insulin acts as a pro-inflammatory hormone, stimulates the sympathetic nervous system, causes sodium retention in the kidneys, promotes cellular proliferation, and dysregulates the RAAS system — the same mechanism implicated in hypertension, stroke risk, and cardiac hypertrophy. |
| 2. Chronic systemic inflammation | Elevated TNF-α, IL-6, IL-1β and C-reactive protein — the same cytokine profile found in T2DM, arthritis, asthma, MS, depression, and ADHD. The inflammatory signal is non-specific: it travels to every organ. Which organ it damages most depends on that individual’s pre-existing vulnerabilities. |
| 3. Gut barrier dysfunction (leaky gut) |
IR drives gut dysbiosis and intestinal permeability, allowing lipopolysaccharides (LPS) from gram-negative bacteria to enter systemic circulation. This “endotoxaemia” is a potent driver of neuroinflammation, autoimmune activation, airway hyperreactivity, and visceral pain — the shared substrate of IBS, asthma, MS, OCD, and ADHD. |
| 4. Impaired cellular energy metabolism | Insulin-resistant cells cannot adequately take up glucose for energy. In neurons, this produces the “brain energy deficit” pattern documented in Alzheimer’s (Type 3 Diabetes), ADHD (prefrontal cortex energy insufficiency), OCD (basal ganglia metabolic disruption), and MS (myelin repair energy failure). |
| 5. Oxidative stress & endothelial dysfunction | Chronic hyperinsulinaemia generates reactive oxygen species and impairs nitric oxide production, causing the arterial wall damage that underpins hypertension, stroke, and cardiovascular disease. The same endothelial dysfunction also impairs kidney filtration (CKD) and retinal circulation (diabetic retinopathy). |
3.2 Why individual physiology determines which condition emerges
The five mechanisms above operate throughout the body simultaneously. The specific condition that emerges — or emerges first — depends on where the individual’s system is most vulnerable. This is not a weakness in the theory; it is the theory’s greatest explanatory strength. Factors that determine an individual’s “path of least resistance” include:
- Constitutional type (Vata, Pitta, Kapha): In Ayurvedic medicine, constitutional typing identifies inherited patterns of physiological vulnerability. Vata types tend toward neurological and gut expression; Pitta toward inflammatory and cardiovascular; Kapha toward metabolic and respiratory. Modern research on individual variation in inflammatory response, gut microbiome composition, and metabolic rate broadly supports this framework.
- Genetic predisposition: Specific gene variants (e.g. HLA-DRB1 for MS and RA, APOE4 for Alzheimer’s, FTO for obesity/ADHD) create tissue-specific vulnerability that IR can exploit.
- Gut microbiome composition: The specific bacterial species present determines which inflammatory signals are amplified. Dysbiosis favouring LPS-producing gram-negative bacteria drives neuroinflammation; dysbiosis favouring methane-producing archaea drives IBS and SIBO.
- Early life exposures: Antibiotic use in childhood, C-section delivery, formula feeding, and early ultra-processed food exposure all shape gut microbiome and immune calibration in ways that create specific disease susceptibility.
- Chronic stress history: The HPA axis (cortisol system) interacts bidirectionally with insulin signalling. Chronic psychological stress raises cortisol, which raises blood glucose, which drives IR — and the loop amplifies whatever downstream vulnerability already exists.
- Nutritional deficiencies: Vitamin D, magnesium, omega-3, and zinc deficiencies — all common in populations eating ultra-processed foods — each impair specific aspects of insulin signalling and immune regulation.
4Condition-by-Condition Mechanism and Evidence
For each of the nine conditions: the primary pathway through which insulin resistance contributes, the physiological reason this particular system is affected, and the key published research supporting the link.
Type 2 Diabetes
Primary causeHypertension
Primary causeMultiple Sclerosis
Major contributorStroke
Primary causeAsthma
Major contributorADHD
Major contributorIBS — Irritable Bowel Syndrome
Major contributorArthritis (OA & RA)
Major contributorOCD
Emerging contributor5Methodology Note — The 50-Year Correlation Data
5.1 Data sources for the IR trend series
- USA: National Health and Nutrition Examination Survey (NHANES) — metabolic syndrome prevalence data 1988–2020. NHANES 2003 analysis (Ford et al.): IR affects ~22% of US adults. NHANES 2021 analysis: 40% of US adults aged 18–44 are IR by HOMA-IR measurement (NCBI NBK507839). Pre-1988 extrapolation uses obesity and fasting glucose trend proxies from CDC National Center for Health Statistics.
- UK: Health Survey for England (HSE) — metabolic syndrome and obesity trend data 1991–2023. UK Biobank metabolic data. Diabetes UK prevalence reports. Pre-1991 extrapolation uses dietary sugar consumption and obesity trend data from the National Food Survey.
5.2 Data sources for each condition’s trend series
| Condition | Trend data sources (USA & UK) | IR role | Key evidence |
|---|---|---|---|
| Type 2 Diabetes | CDC National Diabetes Statistics Report (1980–2023); NHS Digital, Diabetes UK Annual Reports | Primary cause | Whitehall II (Lancet 2009), StatPearls NBK507839, PNAS 2003 |
| Hypertension | NHANES 1988–2018; Muntner et al., JAMA 2020; BHF Heart Statistics, NHS Digital | Primary cause | Ferrannini NEJM 1987, Uppsala study (PMID 24370898) |
| Multiple Sclerosis | Wallin et al., Neurology 2019 (USA); MS Society UK prevalence reports 1990–2022 | Major contributor | Berer et al., Nature 2017; gut–MS studies 2017–2023 |
| Stroke | AHA/ASA Stroke Statistics 1990–2023 (incidence under 65); Stroke Association UK data | Primary cause | Frontiers Endocrinology 2022 systematic review |
| Asthma | CDC NHIS asthma data 1980–2022; Asthma + Lung UK statistics, NHS Digital | Major contributor | Beuther & Sutherland AJRCCM 2007; SARP-3 cohort |
| ADHD | CDC NHIS parent-reported ADHD 1997–2022; Xu et al. JAMA Network Open 2018; NHS England referral data | Major contributor | CDC/NHIS 20-year trend; genetic overlap studies 2022–2026 |
| IBS | Epidemiological estimates 10–15% USA prevalence; NHS/NICE IBS prevalence estimates UK | Major contributor | Reding et al. 2011; systematic review of 49,000 individuals |
| Arthritis | CDC arthritis surveillance data 2002–2023; Versus Arthritis UK statistics | Major contributor | PsA disease activity r=0.77; RA IR prevalence 56% pre-treatment |
| OCD | Epidemiological estimates 1–3%; NHS mental health data UK. Note: long-run surveillance limited. | Emerging link | Animal model data 2025; emerging human research 2025–2026 |
5.3 Citable methodology statement
The Pearson correlation coefficients (r values) presented are 50-year population-level ecological time-series correlations. For each condition, the reported prevalence or incidence trend (USA and UK separately) was indexed to 1975 = 1.0 using published national surveillance data, disease registry data, and epidemiological estimates. The insulin resistance / metabolic syndrome reference series was similarly indexed using NHANES data (USA) and Health Survey for England data (UK), with pre-survey period extrapolation using obesity and dietary proxy measures. Pearson r was calculated between each condition’s indexed series and the IR reference series over the full 50-year period.
Important caveats: (1) Ecological correlation does not establish individual-level causation. (2) Diagnostic expansion, increased clinical awareness, and improved surveillance independently contribute to rising prevalence in all conditions. (3) For IBS and OCD, long-run national surveillance data extending to 1975 is limited; trend estimates in the early period rely on epidemiological modelling rather than continuous surveillance. (4) The stroke series uses incidence data in adults under 65, where IR-driven mechanisms are most directly implicated; stroke mortality has fallen due to improved acute treatment. All r values represent population-level association — not proof of individual causation.
Full dataset and calculation methodology available from For Radiant Health on request.
6Why This Matters Clinically — One Root, One Approach
The conventional medical model treats each of the nine conditions above as a separate disease requiring separate investigation, specialist referral, and medication. A patient with hypertension, IBS, and depression may see three different specialists, receive three different diagnoses, and be prescribed three different medications — none of which address the shared upstream cause.
The insulin resistance model does not deny the validity of these diagnoses. It asks a prior question: why did this person develop these conditions? And it answers: because the biological environment created by chronic insulin resistance allowed these pathways to activate, in the organs and systems where that individual was most vulnerable.
- HOMA-IR testing detects the root cause 10–20 years before most downstream diagnoses. A fasting insulin and glucose test — costing less than a restaurant meal — can identify IR at a stage where the entire disease trajectory remains modifiable.
- Addressing IR simultaneously improves multiple conditions. Clinical evidence from intermittent fasting, low-carbohydrate dietary intervention, gut repair protocols (GAPS), and Transcendental Meditation consistently shows improvements across multiple IR-linked conditions simultaneously — the signature of addressing a shared root cause rather than individual symptoms.
- Individual physiology determines the approach. Because the expression of IR is shaped by constitutional type (Vata, Pitta, Kapha), gut microbiome composition, and genetic vulnerability, the most effective intervention is not a single universal protocol but an approach calibrated to the individual — the foundation of both Ayurvedic medicine and modern integrative health.
7Key References
Primary sources directly supporting the claims on this page and on forradianthealth.com/insulin-resistance-the-root-cause/